Sharma East India Hospitals and Medical Research Limited reported a net profit of ₹124.27 lakh for the financial year ended March 31, 2026, compared to ₹124.43 lakh in the previous year. Total income from operations for the year rose to ₹3,608.91 lakh from ₹3,018.59 lakh in the corresponding period of the previous year. The company's earnings per share (EPS) for the year stood at ₹3.78, marginally lower than the ₹3.79 recorded in the prior year.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹42.92 lakh, an increase from ₹36.69 lakh in the same quarter of the previous year. Total income from operations for the quarter stood at ₹748.71 lakh, up from ₹621.78 lakh in the corresponding quarter of the previous year. The basic and diluted EPS for the quarter was reported at ₹1.31.

The statutory auditors of the company conducted the audit of the financial results for the year ended March 31, 2026, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Audit Committee reviewed the results, which were subsequently approved by the Board of Directors at their meeting held on May 30, 2026.

Financial Performance Summary

The following table outlines the key financial metrics for the quarter and year ended March 31, 2026:

The figures for the previous period or year have been regrouped, rearranged, and/or recast wherever necessary. The detailed format of the quarterly and yearly financial results is available on the company's website and the BSE website.

Sharma East India Hospitals & Medical Research Limited has notified BSE of an upcoming board meeting scheduled for Saturday, May 30, 2026, at its registered office located at Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur. The intimation has been filed under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to transact the following key business:

• Consideration and approval of the Standalone Audited Financial Results along with the Auditor Report for the year ended March 31, 2026, pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015.
• Any other business with the permission of the Chair and with the consent of a majority of Directors present, including at least one Independent Director.

The key details of the scheduled meeting are summarised below:

Trading Window Closure

In accordance with the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the trading window for dealing in the securities of Sharma East India Hospitals & Medical Research Limited has been closed for Designated Persons and their immediate relatives. As communicated by the Company vide its letter dated March 27, 2026, the trading window closure is effective from Wednesday, April 01, 2026, and will remain closed until 48 hours after the declaration of the financial results and their availability as generally available information.

The intimation was signed by Bhawana Sharma, Company Secretary and Compliance Officer (M. No. A61665), on May 15, 2026, from Jaipur.